Study to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid Tumors

Clinical trial NCT05700669 · COMPLETED

Trial details

NCT number: NCT05700669
Sponsor: Valerio Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer Recurrent Epithelial Ovarian Cancer Breast Cancer

Start date: 2023-02-20
Primary completion: 2023-10-31
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.